GSK

GSK sees strong growth as respiratory, cancer portfolio to pay off

Jan 31 (Reuters) - GSK beat market estimates for fourth-quarter results on Wednesday, and unveiled an upbeat forecast for 2024 and beyond, as the drugmaker ramps up its vaccines, infectious…

Read More Here

Curevac, GSK’s new COVID variant vaccine effective in animal studies

FRANKFURT, April 21 (Reuters) - CureVac and GSK's second-generation mRNA vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on rodents, CureVac said. A study in…

Read More Here

GSK says it rejected 50 bln-pound Unilever bid for consumer assets

LONDON, Jan 15 (Reuters) - Pharmaceutical group GlaxoSmithKline said it had rejected a 50-billion-pound ($68.4 billion) bid by Unilever for its consumer healthcare assets which GSK said "fundamentally undervalued" the…

Read More Here

Sanofi, GSK delay data on COVID-19 vaccine booster candidate till 2022

PARIS, Dec 15 (Reuters) - Sanofi and GlaxoSmithKline said on Wednesday they expect data from late-stage clinical trials of its booster dose of their COVID-19 vaccine candidate in the first…

Read More Here

EU signs deal with GSK for supply of potential COVID drug

The European Union has signed a contract with GlaxoSmithKline for the supply of up to 220,000 treatments of its investigational monoclonal antibody therapy sotrovimab against COVID-19, it said on Wednesday.…

Read More Here

EMA advices against second AstraZeneca shot in those with blood clots

The European medicines regulator said on Friday a COVID-19 antibody treatment developed by GSK and Vir Biotechnology can be used to treat patients who are at risk of severe disease…

Read More Here

EU regulator begins real-time review of GSK-Vir’s COVID-19 antibody drug

Europe's medicines regulator said on Friday it has begun a real-time review of the COVID-19 antibody treatment developed by GSK and Vir Biotechnology , formally kicking off the process for…

Read More Here

Vir, GSK to seek emergency use clearance for COVID-19 antibody therapy

Vir Biotechnology and Britain’s GSK plan to seek emergency use authorization for their experimental COVID-19 antibody therapy after interim data from a study showed 85% reduction in hospitalization and deaths…

Read More Here

Pfizer deal: GSK offers concessions to address EU concerns

GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer’s consumer health business, the European Commission said on Thursday. The EU competition enforcer will…

Read More Here

Midday Corporate Dispatch – Financial and Corporate News

Italy will lower its structural deficit next year and is not seeking favors from the European Union, Prime Minister Giuseppe Conte has written in a letter to EU leaders as…

Read More Here

World’s biggest anti-malaria vaccine campaign begins in Africa

Some 360,000 children a year in three African countries are to receive a powerful anti-malaria drug as part of a pilot project to help reduce the incidence of the…

Read More Here